197 related articles for article (PubMed ID: 18069997)
1. Do troponin and B-natriuretic peptide detect cardiomyopathy in transthyretin amyloidosis?
Suhr OB; Anan I; Backman C; Karlsson A; Lindqvist P; Mörner S; Waldenström A
J Intern Med; 2008 Mar; 263(3):294-301. PubMed ID: 18069997
[TBL] [Abstract][Full Text] [Related]
2. Evaluation of myocardial changes in familial amyloid polyneuropathy after liver transplantation.
Okamoto S; Yamashita T; Ando Y; Ueda M; Misumi Y; Obayashi K; Horibata Y; Uchino M
Intern Med; 2008; 47(24):2133-7. PubMed ID: 19075538
[TBL] [Abstract][Full Text] [Related]
3. Circulating matrix metalloproteinases and tissue inhibitors of metalloproteinases in cardiac amyloidosis.
Tanaka K; Essick EE; Doros G; Tanriverdi K; Connors LH; Seldin DC; Sam F
J Am Heart Assoc; 2013 Mar; 2(2):e005868. PubMed ID: 23537813
[TBL] [Abstract][Full Text] [Related]
4. Role of natriuretic peptide to predict cardiac abnormalities in patients with hereditary transthyretin amyloidosis.
Damy T; Deux JF; Moutereau S; Guendouz S; Mohty D; Rappeneau S; Guellich A; Hittinger L; Loric S; Lefaucheur JP; Plante-Bordeneuve V
Amyloid; 2013 Dec; 20(4):212-20. PubMed ID: 23964755
[TBL] [Abstract][Full Text] [Related]
5. Echocardiographic and biohumoral characteristics in patients with AL and TTR amyloidosis at diagnosis.
Cappelli F; Baldasseroni S; Bergesio F; Perlini S; Salinaro F; Padeletti L; Attanà P; Paoletti Perini A; Moggi Pignone A; Grifoni E; Fabbri A; Marchionni N; Gensini GF; Perfetto F
Clin Cardiol; 2015 Feb; 38(2):69-75. PubMed ID: 25645201
[TBL] [Abstract][Full Text] [Related]
6. Usefulness of plasma B-type natriuretic peptide as a prognostic marker of cardiac function in senile systemic amyloidosis and in familial amyloidotic polyneuropathy.
Usuku H; Obayashi K; Shono M; Oshima T; Tasaki M; Yasuda H; Ogawa H; Ando Y
Amyloid; 2013 Dec; 20(4):251-5. PubMed ID: 24111636
[TBL] [Abstract][Full Text] [Related]
7. Cardiac Biomarker Change at 1 Year After Tafamidis Treatment and Clinical Outcomes in Patients With Transthyretin Amyloid Cardiomyopathy.
Kuyama N; Takashio S; Oguni T; Yamamoto M; Hirakawa K; Ishii M; Hanatani S; Oda S; Matsuzawa Y; Usuku H; Yamamoto E; Hirai T; Ueda M; Tsujita K
J Am Heart Assoc; 2024 May; 13(10):e034518. PubMed ID: 38761073
[TBL] [Abstract][Full Text] [Related]
8. Impact of genotype and phenotype on cardiac biomarkers in patients with transthyretin amyloidosis - Report from the Transthyretin Amyloidosis Outcome Survey (THAOS).
Kristen AV; Maurer MS; Rapezzi C; Mundayat R; Suhr OB; Damy T;
PLoS One; 2017; 12(4):e0173086. PubMed ID: 28384285
[TBL] [Abstract][Full Text] [Related]
9. Noninvasive risk stratification of patients with transthyretin amyloidosis.
Kristen AV; Scherer K; Buss S; aus dem Siepen F; Haufe S; Bauer R; Hinderhofer K; Giannitsis E; Hardt S; Haberkorn U; Katus HA; Steen H
JACC Cardiovasc Imaging; 2014 May; 7(5):502-10. PubMed ID: 24726252
[TBL] [Abstract][Full Text] [Related]
10. The Utility of
Moore PT; Burrage MK; Mackenzie E; Law WP; Korczyk D; Mollee P
Heart Lung Circ; 2017 Nov; 26(11):1183-1190. PubMed ID: 28256403
[TBL] [Abstract][Full Text] [Related]
11. Identification of Transthyretin Cardiac Amyloidosis Using Serum Retinol-Binding Protein 4 and a Clinical Prediction Model.
Arvanitis M; Koch CM; Chan GG; Torres-Arancivia C; LaValley MP; Jacobson DR; Berk JL; Connors LH; Ruberg FL
JAMA Cardiol; 2017 Mar; 2(3):305-313. PubMed ID: 28196196
[TBL] [Abstract][Full Text] [Related]
12. Heart complications in familial transthyretin amyloidosis: impact of age and gender.
Hörnsten R; Pennlert J; Wiklund U; Lindqvist P; Jensen SM; Suhr OB
Amyloid; 2010 Jun; 17(2):63-8. PubMed ID: 20462364
[TBL] [Abstract][Full Text] [Related]
13. Diflunisal treatment is associated with improved survival for patients with early stage wild-type transthyretin (ATTR) amyloid cardiomyopathy: the Boston University Amyloidosis Center experience.
Siddiqi OK; Mints YY; Berk JL; Connors L; Doros G; Gopal DM; Kataria S; Lohrmann G; Pipilas AR; Ruberg FL
Amyloid; 2022 Jun; 29(2):71-78. PubMed ID: 35083944
[TBL] [Abstract][Full Text] [Related]
14. Cardiac phenotype and clinical outcome of familial amyloid polyneuropathy associated with transthyretin alanine 60 variant.
Sattianayagam PT; Hahn AF; Whelan CJ; Gibbs SD; Pinney JH; Stangou AJ; Rowczenio D; Pflugfelder PW; Fox Z; Lachmann HJ; Wechalekar AD; Hawkins PN; Gillmore JD
Eur Heart J; 2012 May; 33(9):1120-7. PubMed ID: 21992998
[TBL] [Abstract][Full Text] [Related]
15. Plasma concentrations of NT-pro-BNP and cardiac troponin-I in relation to doxorubicin-induced cardiomyopathy and cardiac function in childhood malignancy.
Soker M; Kervancioglu M
Saudi Med J; 2005 Aug; 26(8):1197-202. PubMed ID: 16127512
[TBL] [Abstract][Full Text] [Related]
16. Progression of cardiomyopathy after liver transplantation in patients with familial amyloidotic polyneuropathy, Portuguese type.
Olofsson BO; Backman C; Karp K; Suhr OB
Transplantation; 2002 Mar; 73(5):745-51. PubMed ID: 11907421
[TBL] [Abstract][Full Text] [Related]
17. Combination of Commonly Examined Parameters Is a Useful Predictor of Positive
Marume K; Takashio S; Nishi M; Hirakawa K; Yamamoto M; Hanatani S; Oda S; Utsunomiya D; Shiraishi S; Ueda M; Yamashita T; Sakamoto K; Yamamoto E; Kaikita K; Izumiya Y; Yamashita Y; Ando Y; Tsujita K
Circ J; 2019 Jul; 83(8):1698-1708. PubMed ID: 31189791
[TBL] [Abstract][Full Text] [Related]
18. Myocardial hypertrophy and function are related to age at onset in familial amyloidotic polyneuropathy.
Suhr OB; Lindqvist P; Olofsson BO; Waldenström A; Backman C
Amyloid; 2006 Sep; 13(3):154-9. PubMed ID: 17062381
[TBL] [Abstract][Full Text] [Related]
19. Detection of cardiac sarcoidosis using cardiac markers and myocardial integrated backscatter.
Yasutake H; Seino Y; Kashiwagi M; Honma H; Matsuzaki T; Takano T
Int J Cardiol; 2005 Jul; 102(2):259-68. PubMed ID: 15982494
[TBL] [Abstract][Full Text] [Related]
20. A multi-modal diagnostic model improves detection of cardiac amyloidosis among patients with diagnostic confirmation by cardiac biopsy.
Zhang KW; Zhang R; Deych E; Stockerl-Goldstein KE; Gorcsan J; Lenihan DJ
Am Heart J; 2021 Feb; 232():137-145. PubMed ID: 33212046
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
